drugset / Trial / NCT01988922
CYP2B6 Polymorphisms in Ketamine
Non-randomizedSingle-groupOpen-labelOther
Summary
This research study will determine if genetic variation in CYP2B6 affects how the body metabolizes ketamine.
Timeline
- Start
- 2013-11
- Primary completion
- 2016-05
- Completion
- 2017-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.4 mg/kg | Oral |
Indications
No indication recorded.